technetium tc 99m hydroxymethylene diphosphonate has been researched along with Cancer of Parathyroid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Geeter, F; De Vriese, A; Decock, A; Depaepe, P; Van den Bruel, A | 1 |
| Abe, M; Miyagawa, M; Nishimura, K; Ohnishi, H | 1 |
| Koyano, H; Schimizu, T; Shishiba, Y | 1 |
| Antón, A; Caballero, O; Martínez, A; Serrano, J; Verdú, J | 1 |
4 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Cancer of Parathyroid
| Article | Year |
|---|---|
A bone scan, no mistake!
Topics: Bone and Bones; Calcinosis; Humans; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2014 |
Tl-201, Tc-99m sestamibi, and Tc-99m HMDP uptake in multiple brown tumors.
Topics: Adenocarcinoma, Papillary; Bone Neoplasms; Clavicle; Female; Humans; Middle Aged; Parathyroid Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Ribs; Sternum; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thallium; Whole-Body Counting | 2003 |
The bisphosphonate dilemma.
Topics: Alendronate; Bone and Bones; Bone Neoplasms; Clodronic Acid; Diphosphonates; False Negative Reactions; Female; Humans; Hypercalcemia; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Technetium Tc 99m Medronate | 1995 |
[Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
Topics: Bone and Bones; Bone Diseases, Metabolic; Carcinoma; Contrast Media; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Time Factors | 1998 |